acyclovir decreased the incidence of documented cytomegalovirus infection ( with or without symptomatic disease ) to 36 percent from 61 percent among the patients who received the placebo ( p = 0.011 ) .
C0001367
acyclovir
C0010823
cytomegalovirus infection